IMA vs BIIB: Which Stock is Better?
Side-by-side comparison of Imagenebio Inc and Biogen Inc in 2026
IMA
Imagenebio Inc
$4.90
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | IMA | BIIB | Winner |
|---|---|---|---|
| Market Cap | $54.83M | $25.88B | BIIB |
| P/E Ratio | N/A | 20.09 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 100.0% | 78.9% | IMA |
Analyze IMA
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMA or BIIB a better investment?
Comparing IMA and BIIB: Imagenebio Inc has a market cap of $54.83M while Biogen Inc has $25.88B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMA and BIIB?
IMA (Imagenebio Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMA or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMA or BIIB?
IMA has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: IMA or BIIB?
Imagenebio Inc (IMA) has higher gross margins at 100.0% compared to 78.9% for BIIB.
Which is the larger company: IMA or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.88B compared to $54.83M for IMA.
Should I buy IMA or BIIB in 2026?
Both IMA and BIIB have investment merit. IMA trades at $4.90 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMA and BIIB stock?
Key differences: Market Cap ($54.83M vs $25.88B), P/E Ratio (N/A vs 20.1x), Revenue Growth (0.0% vs -0.1%), Gross Margin (100.0% vs 78.9%).